- Has Twitter's Finest Hours (Seconds) Come and Gone?
- Intel's Andy Bryant Offers An Explanation
- Apple's Global Retail Invasion
- Intel Settles; AMD Settles the Score
- HP's Shot Across Cisco's Bow
- Back Off, Regulators!
- iPhone, App Strategy the 'New Dot Com?'
- Cisco Jumps; Rest of Market to Follow?
- Call It 'Microsoft Math'
- Intel in the Anti-Trust Crosshairs, but Why?
MOST SHARED
- Seeking Innovation in Health Care
- Driving Health Care Innovation
- Next Week’s Top IPO
- Warren Buffett and Bill Gates: Keeping America Great
- Herbalife Vs. Hedge Funds
- Novo Nordisk CEO on Diabetes Epidemic
- Burned by Yahoo!, Disney and More
- Cramer: 5 Earnings Reports to Watch Next Week
- Fast Fire
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
- First Time Buyers Rescue Housing: Realtors
- Dollar General Trades Higher After Its IPO
- Fed Reform? Not So Fast.
- Oil Next Week: What Traders Will Be Watching

- Hedge Fund Billionaire Paulson Reports New Citi Stake
- Cramer: 5 Earnings Reports to Watch Next Week
- Court Rejects 'Clawbacks' for Alleged Stanford Victims
- Tax Credit Sparking First-Time Home Sales: Realtors
- Investors Cut Back US Stocks for Bigger Growth Abroad
- Cities With the Most Home Price Reductions
- White House Plans to Freeze Spending to Cut Deficit
- This Year's Biggest Thanksgiving Leftover: Cash
- Oil Next Week: What Traders Will Be Watching
RSS FEED
Tech Check
![]() |
Competing missives today from The Wall Street Journal and the New York Times about the latest in the does-he-or-doesn't-he-have-cancer, or is-Apple-lying sweepstakes.
If I sound a little flip, my apologies, but the real nuggets of news buried deep within the noise, are getting lost. It's like we're all too busy focusing on the action away from the ball and missing the real news. Even though it's right in front of us. More on that in a second.
First, The Wall Street Journal reports that one hedge fund apparently hired a private investigator to track Steve Jobs and his hospital visits, hoping for some insight into how sick he was. That was back in 2004 soon after he was diagnosed with a rare form of pancreatic cancer. Pretty disturbing stuff.
At the same time, The New York Times cites several sources close to Jobs who tell the paper he has told them that he's doing well and cancer free, that he did have some surgery earlier this year to address a problem that was leading to a loss of weight.
![]() |
Steve Jobs |
I have little doubt that both those stories are true. Unlike earlier reports this week from Henry Blodget's Silicon Alley Insider and the New York Post, both citing nameless, faceless hedge fund managers as "worried" about Steve Jobs and his health. Curious that those stories would come out the day Apple[AAPL
Loading...
()
] was preparing to release earnings. Blodget has made it his personal crusade to get Apple to disclose the real truth behind Jobs and his illness. Full disclosure, he says, is only fair, and right. That Apple is mis-leading its investors. And needs to stop. Puh-lease. Does anybody catch the irony here of a disclosure-challenged Blodget coming to the rescue of "misled" investors?
But I digress. The simple truth is this: Apple knows that it must disclose Jobs' health status if it is somehow material to the company. By not disclosing his health issues, and calling them a private matter, Apple is tacitly telling all of us that whatever is ailing Jobs is not serious enough to be material to the company. That doesn't mean it might not rise to that level at some point, but for now, it doesn't. Could it tomorrow? Sure. Anything's possible. But you could have been saying, "could it tomorrow" since the day after his 2004 cancer diagnosis was made public.
Bottomline: Apple can't comment on rumors. Doesn't comment on rumors. And shouldn't. If it starts now, it'll have to comment all the time. Disagree? Consider: If I were to call Apple and say, "Rumors are that Steve's cancer is back." Apple responds, "No, it's not." Two days later, I call Apple and say, "Rumors are, Apple's adopting Windows as its new operating system." Apple responds, "We can't comment." Hmmmm, denying one rumor, but not commenting on another? Seems pretty clear that Apple will be adopting Windows as its new operating system. Once you address one rumor, you have to address them all. And with Apple, the company would have to hire an army of employees to handle the task. Kinda like dealing with kidnappers. Pay a ransom to one, and pretty soon, kidnappings skyrocket. Just look at Central and South America.
Again, I digress. Trust is a tricky thing. It's something earned. True that Apple didn't disclose Jobs' original cancer diagnosis until it absolutely had to. But even then, it was adhering to the law. And met that bar. And there simply is no reason to believe anything otherwise is happening today.
During the stock options back-dating mess last year, the company was forthcoming, Jobs himself was extremely candid in answering my direct questions to him about that controversy. And even the SEC took the extraordinary step of thanking Apple for its "extraordinary" cooperation. With billions of dollars hanging in the balance, thousands of jobs, Jobs' and Apple's legacy, I know the stakes are huge, and that people can do silly things when it comes to protecting all that. All that aside, if trust is earned, Apple has earned my trust and has done nothing to shake it. That's not to say they won't. Or can't. But for now, I err on the side of taking Apple at its word.
Until the company gives me a solid reason not to. Which it hasn't. Kind of like Jobs and his health. It's material when it's material. Until then, it isn't. We might all have a prurient interest in Jobs and his private life, but prurient doesn't trump material. And "material" is all that matters. Which it's not. For now.
Questions? Comments?










